|
Innate immune cell therapies (e.g. activation, inhibition pathways, therapies, toxicities) |
|
Enduring |
|
$25.00 |
|
Quantitative systems pharmacology/ toxicology modeling for IO therapies |
|
Enduring |
|
$25.00 |
|
Immunopathology: evaluation, assessment, and considerations |
|
Enduring |
|
$25.00 |
|
Neurotoxicity across Cancer Modalities |
|
Enduring |
|
$25.00 |
|
Assessing adversity in immunosafety (preclinical) |
|
Enduring |
|
$25.00 |
|
Regulatory Considerations for Cancer Immunotherapies: Preclinical Focus |
|
Enduring |
|
$25.00 |
|
Immune-related adverse events (clinical) |
|
Enduring |
|
$25.00 |
|
Innate immune cell therapies (e.g. activation, inhibition pathways, therapies, toxicities) |
|
Enduring |
|
$25.00 |
|
Animal models and species differences (immune system) |
|
Enduring |
|
$25.00 |
|
Diversity of immune responses (impact of age, sex, pregnancy, co-morbidities, etc.) |
|
Enduring |
|
$25.00 |
|
Diversity of immune responses (impact of age, sex, pregnancy, co-morbidities, etc.) |
|
Enduring |
|
$25.00 |
|
Regulatory guidance: Introduction |
|
Enduring |
|
$25.00 |
|
Overview of Cancer Immunotherapies |
|
Enduring |
|
$35.00 |
|
An Introduction to Immuno-Safety Science |
|
Enduring |
|
$350.00 |
|
Cancer Immunotherapies |
|
Enduring |
|
$350.00 |
Facebook
Twitter
LinkedIn
Forward